STAT Wunderkinds discuss high-impact research, resilience, and social justice
At an event highlighting past STAT Wunderkinds, one researcher spoke to the importance of physicians paying attention to issues beyond the clinic room: "There's so much that affects people's health.”
Elenoe “Crew” Smith used to faint at the sight of blood. Still, she knew from a very young age that she wanted to help people living with sickle cell disease. Now, as a research director at Vertex Pharmaceuticals, she is working on potential sickle cell medicines.
Smith was in STAT’s 2017 class of Wunderkinds, an annual selection of standout researchers who are launching their careers. She and a Wunderkind from the class of 2020, Altaf Saadi, assistant professor of neurology at Massachusetts General Hospital and Harvard Medical School, spoke at a virtual STAT event Thursday about their journeys in science and medicine — what their work is, what brought them to the field, and what keeps them going.
What's Your Reaction?
